690PCLINICAL IMPACT OF FOLFIRINOX DOSE/SCHEDULE MODIFICATIONS (MFOLFORINOX) AND ADDITIONAL SUPPORTIVE MEASURES IN THE MANAGEMENT OF PANCREATIC CANCER (PDAC) PATIENTS (PTS)
Vaccaro, V., Sperduti, I., Melisi, D., Bria, E., Vasile, E., Santoni, M., Giordano, G., Bertocchi, P., Lucchini, E., Pino, M.S., Gelibter, A., Garufi, C., Zeuli, M., Zaniboni, A., Febbraro, A., CascinVolume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu334.75
Date:
September, 2014
File:
PDF, 67 KB
2014
File converter
More search results
More benefits 
